Delirium after stroke linked to poorer outcomes for patients

 

Toronto, Ont., Canada (January 19, 2012) – Up to 30 per cent of patients hospitalized after a stroke develop delirium, according to a new study from St. Michael’s Hospital. Researchers found patients who experience delirium after stroke are five times more likely to die, and are more likely to be discharged to a long-term care facility, nursing home or have a longer stay in hospital.

 

"Early recognition and prevention of delirium are important for a quick recovery, better quality of life and timely discharge for patients who have suffered a stroke," said Dr. Gustavo Saposnik, lead author of the paper and director of the Stroke Outcomes Research Centre at the hospital.

 

Saposnik and colleagues analyzed 10 studies that looked at the four common outcomes in over 2.000 patients with delirium – inpatient and 12-month death rates, length of hospital stay and care arrangements after discharge.

 

Unlike dementia – a chronic, progressive mental disorientation – delirium is an acute, sudden state of confusion is often marked by lack of attention, disorientation, and sometimes hallucination.

 

Patients can become delirious at any time after a stroke, however when it occurs seven to 10 days later it is commonly related to a complication such as a respiratory or urinary infection, instead of as part of the stroke’s effects.

 

Recognizing the associated risk factors such as age, severity of stroke, infections, narcotic use, lack of oxygen and cognitive impairment can help clinicians identify initial signs of delirium and use early interventions.

 

The paper is published in Stroke: Journal of the American Heart Association.

 

Saposnik said this research aims to encourage early detection and intervention to improve outcomes for patients and families, but further research is needed to understand the most effective interventions.

 

St. Michael’s Hospital has developed the Delirium Prevention Program (DPP) to reduce the occurrence of delirium – especially in elderly patients – and to improve patients‘ experience.

 

The DPP is a multi-disciplinary team approach that uses simple strategies in everyday care to help keep patients oriented. Clocks have been installed in every patient’s room along with whiteboards, on which the date is written daily; Lights on the orthopedic unit and overhead paging systems are turned off at night to minimize confusion over time of day; and blinds are opened daily so patients have natural light rhythms.

 

 

About St. Michael’s Hospital

 

St. Michael’s Hospital provides compassionate care to all who enter its doors. The Hospital also provides outstanding medical education to future health care professionals in more than 23 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, and care of the homeless are among the Hospital’s recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing Knowledge Institute, research at St. Michael’s Hospital is recognized and put into practice around the world. Founded in 1892, the Hospital is fully affiliated with the University of Toronto.

 

 


St. Michael’s Hospital, 19.01.2012 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…